Lithium Carbonate Tablet, Extended Release
Product Images NDC 70518-0608

5 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 70518-0608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lithium Fi-1 (Lithium Fi 1)

Lithium Fi-1 (Lithium Fi 1)
A dosing schedule table for Lithium Carbonate extended-release tablets for acute mania, showing administration of 3 tablets (900 mg) in the morning and 3 tablets (900 mg) at nighttime, with a note indicating an alternative dosing of 600 mg three times daily.*
FDA Label Image

Litium Fi-2 (Litium Fi 2)

Litium Fi-2 (Litium Fi 2)
A dosing schedule table titled 'Long-Term Control' for lithium carbonate extended-release tablets. It specifies taking 2 tablets (600 mg total) in the morning and 2 tablets (600 mg total) at nighttime, with no afternoon dose indicated.*
FDA Label Image

Mm1 (Lithium Carbonate 300mg 70518 0608 00)

Mm1 (Lithium Carbonate 300mg 70518 0608 00)
Lithium Carbonate Extended-Release Tablets 300 mg in a bottle containing 30 tablets. The label shows the NDC number 70518-0608-00 and indicates the product is repackaged by RemedyRepack Inc., located in Indiana, PA. Storage instructions and a QR code are also visible on the label.*
FDA Label Image

Mm2 (Lithium Carbonate 300mg 70518 0608 01)

Mm2 (Lithium Carbonate 300mg 70518 0608 01)
Lithium Carbonate 300 mg extended-release oral tablets, packaged 100 per box. The label shows the proprietary and generic name, dosage form, strength, quantity, and the labeler RemedyRepack Inc. It includes storage instructions and contact information for RemedyRepack in Indiana, PA.*
FDA Label Image

Mm3 (Lithium Carbonate 300mg 70518 0608 02)

Mm3 (Lithium Carbonate 300mg 70518 0608 02)
Lithium Carbonate 300 mg extended-release tablet packaging label. The label indicates a quantity of 1 tablet with NDC 70518-0608-02. It is repackaged by RemedyRepack Inc., Indiana, PA. The original manufacturer is Rising Pharma, Inc., Allendale, NJ. Additional text includes standard storage instructions and dosage directions referencing the insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.